Tourniglo is the world’s first multi-use, quick-release phlebotomy tourniquet with a built-in torch. Its potential has been recognised by retailers and distributors who have expressed interest in stocking the Tourniglo. The global tourniquet market is anticipated to expand at a CAGR of 8%.
Tourniglo is the first branded, multi-use, phlebotomy tourniquet with a built-in torch in the world (patent-pending). Its design was driven by an identified need within the emergency services to provide an immediately available light source in darkened areas when undertaking a patient or casualty eye examination, or when looking for their vital sign that can reduce the decision-making time for taking drastic action.
It also has important applications for military and close protection staff who might need to inject intravenous medication in rural areas. Its versatile use can potentially make it an essential element of a first aid kit, as well as of bleeding kits.
The global tourniquet market is forecast to witness a CAGR of 8% between 2018–2024. The global tourniquet systems market is expected to reach $594.8m by 2025.
Dr Stratos Sofos created early prototypes and founded Tourniglo Ltd in 2012. Alexander joined the company in 2015, and with his design engineering background the product evolved into its current form. Since late 2018, we have received buying interest from retailers and distributors.
Tourniglo has been featured on the BBC website and has won various medals at international events, including Gold at the World Invention Awards.
This seed funding will be used to set-up manufacturing, packaging and distribution, and grow sales for the first year of commercialisation.